Thyroid Physiology and Diagnostic Evaluation of Patients with Thyroid Disorders

Williams Textbook of Endocrinology, Twelfth Edition

Volumn , Issue , 2011, Pages 327-361

  Salvatore, Domenico ^a   Davies, Terry F ^b   Schlumberger, Martin Jean ^c,d   Hay, Ian D ^e   Larsen, P Reed ^f,g  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Mayo Clinic College of Medicine   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879191742     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0324-5.00011-0     Document Type: Chapter

References (197)

1. M De Felice and R Di Lauro (2007) Murine models for the study of thyroid gland development. Endocr Dev 10 1-14.
2. J Kratzsch and F Pulzer (2008) Thyroid gland development and defects. Best Pract Res Clin Endocrinol Metab 22 57-75.
3. SM Park and VK Chatterjee (2005) Genetics of congenital hypothyroidism. J Med Genet 42 379-389.
4. GN Burrow, DA Fisher and PR Larsen (1994) Mechanisms of disease: maternal and fetal thyroid function. N Engl J Med 331 1072-1078.
5. D Glinoer (2007) Clinical and biological consequences of iodine deficiency during pregnancy. Endocr Dev 10 62-85.
6. KL Caldwell, GA Miller, RY Wang, et al. (2008) Iodine status of the U.S. population: National Health and Nutrition Examination Survey 2003-2004. Thyroid 18 1207-1214.
7. O Dohan, A De la Vieja, V Paroder, et al. (2003) The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24 48-77.
8. J Wolff (1998) Perchlorate and the thyroid gland. Pharmacol Rev 50 89-105.
9. A De La Vieja, O Dohan, O Levy, et al. (2000) Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80 1083-1105.
10. J Van Sande, C Massart, R Beauwens, et al. (2003) Anion selectivity by the sodium iodide symporter. Endocrinology 144 247-252.
11. J Wolff (1983) Congenital goiter with defective iodide transport. Endocr Rev 4 240-254.
12. A Bizhanova and P Kopp (2009) Minireview: the sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 150 1084-1090.
13. LA Everett, H Morsli, DK Wu, et al. (1999) Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci U S A 96 9727-9732.
14. LA Everett and ED Green (1999) A family of mammalian anion transporters and their involvement in human genetic diseases. Hum Mol Genet 8 1883-1891.
15. IE Royaux, SM Wall, LP Karniski, et al. (2001) Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A 98 4221-4226.
16. ME Morgans and WR Trotter (1958) Association of congenital deafness with goitre: the nature of the thyroid defect. Lancet 1 607-609.
17. P Kopp, L Pesce and SJ Solis (2008) Pendred syndrome and iodide transport in the thyroid. Trends Endocrinol Metab 19 260-268.
18. AM Rodriguez, B Perron, L Lacroix, et al. (2002) Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 87 3500-3503.
19. V Paroder, SR Spencer, M Paroder, et al. (2006) Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT. Proc Natl Acad Sci U S A 103 7270-7275.
20. MF van den Hove, K Croizet-Berger, F Jouret, et al. (2006) The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. Endocrinology 147 1287-1296.
21. S Gnidehou, B Caillou, M Talbot, et al. (2004) Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site. FASEB J 18 1574-1576.
22. PR Larsen (1975) Thyroidal triiodothyronine and thyroxine in Graves’ disease: correlation with presurgical treatment, thyroid status, and iodine content. J Clin Endocrinol Metab 41 1098-1104.
23. JC Moreno, W Klootwijk, H van Toor, et al. (2008) Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med 358 1811-1818.
24. A Taurog, ML Dorris and DR Doerge (1996) Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase. Arch Biochem Biophys 330 24-32.
25. C Ris-Stalpers (2006) Physiology and pathophysiology of the DUOXes. Antioxid Redox Signal 8 1563-1572.
26. H Grasberger and S Refetoff (2006) Identification of the maturation factor for dual oxidase: evolution of an eukaryotic operon equivalent. J Biol Chem 281 18269-18272.
27. P Niethammer, C Grabher, AT Look, et al. (2009) A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459 996-999.
28. T Vulsma, MH Gons and JMM DeVijlder (1989) Maternal fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid dysgenesis. N Engl J Med 321 13-16.
29. JC Moreno, H Bikker, MJ Kempers, et al. (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 347 95-102.
30. I Zamproni, H Grasberger, F Cortinovis, et al. (2008) Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 93 605-610.
31. B Bakker, H Bikker, T Vulsma, et al. (2000) Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab 85 3708-3712.
32. AC Gerard, C Daumerie, C Mestdagh, et al. (2003) Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol Metab 88 4977-4983.
33. AD Dunn, CM Corsi, HE Myers, et al. (1998) Tyrosine 130 is an important outer ring donor for thyroxine formation in thyroglobulin. J Biol Chem 273 25223-25229.
34. J Abuid and PR Larsen (1974) Triiodothyronine and thyroxine in hyperthyroidism: comparison of the acute changes during therapy with antithyroid agents. J Clin Invest 54 201-208.
35. RS Bahn, HS Burch, DS Cooper, et al. (2009) The role of propylthiouracil in the management of Graves’ disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19 673-674.
36. BW Kim, GH Daniels, BJ Harrison, et al. (2003) Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J Clin Endocrinol Metab 88 594-598.
37. JH Lazarus (1998) The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8 909-913.
38. TF Davies, T Ando, RY Lin, et al. (2005) Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest 115 1972-1983.
39. B Corvilain, J Van Sande, JE Dumont, et al. (2001) Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin Endocrinol (Oxf) 55 143-158.
40. AP Saavedra, OM Tsygankova, GV Prendergast, et al. (2002) Role of cAMP, PKA and Rap1A in thyroid follicular cell survival. Oncogene 21 778-788.
41. F Cianfarani, E Baldini, A Cavalli, et al. (2010) TSH receptor and thyroid-specific gene expression in human skin. J Invest Dermatol 130 93-101.
42. M Tonacchera, J Van Sande, J Parma, et al. (1996) TSH receptor and disease. Clin Endocrinol (Oxf) 44 621-633.
43. AC Bianco, D Salvatore, B Gereben, et al. (2002) Biochemistry, cellular and molecular biology and physiological roles of the iodothyronine selenodeiodinases. Endocrine Rev 23 38-89.
44. BR Haugen (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23 793-800.
45. KA Findlay, E Kaptein, TJ Visser, et al. (2000) Characterization of the uridine diphosphate-glucuronosyltransferase-catalyzing thyroid hormone glucuronidation in man. J Clin Endocrinol Metab 85 2879-2883.
46. GC Schussler (2000) The thyroxine-binding proteins. Thyroid 10 141-149.
47. B Jirasakuldech, GC Schussler, MG Yap, et al. (2000) A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. J Clin Endocrinol Metab 85 3996-3999.
48. PA Pemberton, PE Stein, MB Pepys, et al. (1988) Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336 257-258.
49. PW Dickson, AR Aldred, PD Marley, et al. (1986) Rat choroid plexus specializes in the synthesis and secretion of transthyretin (prealbumin). J Biol Chem 261 3475-3478.
50. JA Palha, V Episkopou, S Maeda, et al. (1994) Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 269 33135-33139.
51. JA Palha, R Fernandes, GM de Escobar, et al. (2000) Transthyretin regulates thyroid hormone levels in the choroid plexus, but not in the brain parenchyma: study in a transthyretin-null mouse model. Endocrinology 141 3267-3272.
52. L Bartalena (1990) Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev 11 47-64.
53. L Bartalena (1994) Thyroid hormone-binding proteins: update 1994. Endocr Rev 3 140-142.
54. W Chin and GC Schussler (1968) Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin. J Clin Endocrinol 28 181-186.
55. PR Larsen (1972) Salicylate-induced increases in free triiodothyronine in human serum. Evidence of inhibition of triiodothyronine binding to thyroxine-binding globulin and thyroxine-binding prealbumin. J Clin Invest 51 1125-1134.
56. R Docter, G Bos, EP Krenning, et al. (1981) Inherited thyroxine excess: a serum abnormality due to an increased affinity for modified albumin. Clin Endocrinol 15 363-371.
57. CM Mendel and RR Cavalieri (1984) Thyroxine distribution and metabolism in familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab 59 499-504.
58. BM Arafah (2001) Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 344 1743-1749.
59. J Robbins and JE Rall (1957) The interaction of thyroid hormones and protein in biological fluids. Recent Prog Horm Res 13 161-202. discussion 202-208
60. CM Mendel (1989) The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 10 232-274.
61. H Heuer and TJ Visser (2009) Minireview: pathophysiological importance of thyroid hormone transporters. Endocrinology 150 1078-1083.
62. CM Mendel, RA Weisiger, AL Jones, et al. (1987) Thyroid hormone-binding proteins in plasma facilitate uniform distribution of thyroxine withing tissues: a perfused rat liver study. Endocrinology 120 1742-1749.
63. WE Visser, EC Friesema, J Jansen, et al. (2008) Thyroid hormone transport in and out of cells. Trends Endocrinol Metab 19 50-56.
64. AM Dumitrescu, XH Liao, RE Weiss, et al. (2006) Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147 4036-4043.
65. M Trajkovic, TJ Visser, J Mittag, et al. (2007) Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117 627-635.
66. H Heuer, MK Maier, S Iden, et al. (2005) The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146 1701-1706.
67. J Bernal (2005) The significance of thyroid hormone transporters in the brain. Endocrinology 146 1698-1700.
68. HM Tu, SW Kim, D Salvatore, et al. (1997) Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138 3359-3368.
69. A Guadano-Ferraz, MJ Escamez, E Rausell, et al. (1999) Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J Neurosci 19 3430-3439.
70. DL St Germain, VA Galton and A Hernandez (2009) Minireview: defining the roles of the iodothyronine deiodinases—current concepts and challenges. Endocrinology 150 1097-1107.
71. MJ Berry, L Banu and PR Larsen (1991) Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349 438-440.
72. MJ Berry and PR Larsen (1992) The role of selenium in thyroid hormone action. Endocr Rev 13 207-219.
73. MJ Berry, L Banu, YY Chen, et al. (1991) Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353 273-276.
74. B Gereben, AM Zavacki, S Ribich, et al. (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29 898-938.
75. SA Huang (2005) Physiology and pathophysiology of type 3 deiodinase in humans. Thyroid 15 875-881.
76. D Salvatore, SC Low, M Berry, et al. (1995) Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J Clin Invest 96 2421-2430.
77. M Dentice, R Ambrosio and D Salvatore (2009) Role of type 3 deiodinase in cancer. Expert Opin Ther Targets 13 1363-1373.
78. SA Huang, HM Tu, JW Harney, et al. (2000) Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343 185-189.
79. A Hernandez (2005) Structure and function of the type 3 deiodinase gene. Thyroid 15 865-874.
80. DL St Germain, A Hernandez, MJ Schneider, et al. (2005) Insights into the role of deiodinases from studies of genetically modified animals. Thyroid 15 905-916.
81. VA Galton, MJ Schneider, AS Clark, et al. (2009) Life without thyroxine to 3,5,3′-triiodothyronine conversion: studies in mice devoid of the 5′-deiodinases. Endocrinology 150 2957-2963.
82. MJ Schneider, SN Fiering, B Thai, et al. (2006) Targeted disruption of the type 1 selenodeiodinase gene (dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147 580-589.
83. A Hernandez, ME Martinez, S Fiering, et al. (2006) Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 116 476-484.
84. M Saberi, FH Sterling and RD Utiger (1975) Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest 55 218-223.
85. MA Christoffolete, R Ribeiro, P Singru, et al. (2006) Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary TSH feedback mechanism. Endocrinology 147 1735-1743.
86. SY Wu, WL Green, WS Huang, et al. (2005) Alternate pathways of thyroid hormone metabolism. Thyroid 15 943-958.
87. MO Ribeiro, SD Carvalho, JJ Schultz, et al. (2001) Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J Clin Invest 108 97-105.
88. SA Huang and AC Bianco (2008) Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pract Endocrinol Metab 4 148-155.
89. E Martino, L Bartalena, F Bogazzi, et al. (2001) The effects of amiodarone on the thyroid. Endocr Rev 22 240-254.
90. JS LoPresti, A Eigen, E Kaptein, et al. (1989) Alterations in 3,3′,5′-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J Clin Invest 84 1650-1656.
91. L Schomburg and J Kohrle (2008) On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 52 1235-1246.
92. MA Lazar (2003) Thyroid hormone action: a binding contract. J Clin Invest 112 497-499.
93. LL Amma, A Campos-Barros, Z Wang, et al. (2001) Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Mol Endocrinol 15 467-475.
94. ED Abel, HC Kaulbach, A Campos-Barros, et al. (1999) Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin. J Clin Invest 103 271-279.
95. D Forrest, G Golarai, J Connor, et al. (1996) Genetic analysis of thyroid hormone receptors in development and disease. Recent Prog Horm Res 51 1-22.
96. M Togashi, S Borngraeber, B Sandler, et al. (2005) Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. J Steroid Biochem Mol Biol 93 127-137.
97. JH Bassett, CB Harvey and GR Williams (2003) Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213 1-11.
98. SA Mousa, LJ O’Connor, JJ Bergh, et al. (2005) The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol 46 356-360.
99. AN Hollenberg, T Monden, TR Flynn, et al. (1995) The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Mol Endocrinol 9 540-550.
100. TP Segerson, J Kauer, H Wolfe, et al. (1987) Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 238 78-80.
101. EM Dyess, TP Segerson, Z Liposits, et al. (1988) Triiodothyronine exerts direct cell-specific regulation of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology 123 2291-2297.
102. RM Lechan and C Fekete (2005) Role of thyroid hormone deiodination in the hypothalamus. Thyroid 15 883-897.
103. H Heuer, MK Schafer and K Bauer (1998) The thyrotropin-releasing hormone-degrading ectoenzyme: the third element of the thyrotropin-releasing hormone-signaling system. Thyroid 8 915-920.
104. JA Magner (1990) Thyroid-stimulating hormone: biosynthesis, cell biology and bioactivity. Endocr Rev 11 354-385.
105. N Gesundheit, PA Petrick, M Nissim, et al. (1989) Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Ann Intern Med 11 827-835.
106. P Beck-Peccoz, S Amir, MM Menezes-Ferreira, et al. (1985) Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism: effect of treatment with thyrotropin-releasing hormone. N Engl J Med 312 1085-1090.
107. JL Chan, K Heist, AM DePaoli, et al. (2003) The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 111 1409-1421.
108. G Brabant, K Frank and U Ranft (1990) Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab 70 403-409.
109. AA Nikrodhanond, TM Ortiga-Carvalho, N Shibusawa, et al. (2006) Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem 281 5000-5007.
110. MI Chiamolera and FE Wondisford (2009) Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150 1091-1096.
111. P Beck-Peccoz, F Brucker-Davis, L Persani, et al. (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17 610-638.
112. BM Biller, ME Molitch, ML Vance, et al. (1996) Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 81 2338-2343.
113. SI Sherman, J Gopal, BR Haugen, et al. (1999) Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 340 1075-1079.
114. V Sharma, WR Hays, WM Wood, et al. (2006) Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis. Endocrinology 147 1438-1451.
115. K Nakabayashi, H Matsumi, A Bhalla, et al. (2002) Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest 109 1445-1452.
116. SC Sun, PJ Hsu, FJ Wu, et al. (2010) Thyrostimulin, but not thyroid-stimulating hormone, acts as a paracrine regulator to activate thyroid-stimulating hormone receptor in the mammalian ovary. J Biol Chem 285 3758-3765.
117. G Riesco, A Taurog, R Larsen, et al. (1977) Acute and chronic responses to iodine deficiency in rats. Endocrinology 100 303-313.
118. R Peeters, C Fekete, C Goncalves, et al. (2001) Regional physiological adaptation of the central nervous system deiodinases to iodine deficiency. Am J Physiol Endocrinol Metab 281 E54-E61.
119. TW Guo, FC Zhang, MS Yang, et al. (2004) Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China. J Med Genet 41 585-590.
120. CC Pazos-Moura, EG Moura, ML Dorris, et al. (1991) Effect of iodine deficiency and cold exposure on thyroxine 5′-deiodinase activity in various rat tissues. Am J Physiol 260 E175-E182.
121. MB Zimmermann (2009) Iodine deficiency. Endocr Rev 30 376-408.
122. F Delange (1994) The disorders induced by iodine deficiency. Thyroid 4 107-128.
123. J Wolff and IL Chaikoff (1948) Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174 555-564.
124. PH Eng, GR Cardona, SL Fang, et al. (1999) Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140 3404-3410.
125. SO LeBeau and SJ Mandel (2006) Thyroid disorders during pregnancy. Endocrinol Metab Clin North Am 35 117-136. vii
126. D Glinoer (2004) The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. Best Pract Res Clin Endocrinol Metab 18 133-152.
127. JS Dashe, BM Casey, CE Wells, et al. (2005) Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 106 753-757.
128. SA Huang, DM Dorfman, DR Genest, et al. (2003) Type 3 Iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol and Metabolism 88 1384-1388.
129. EK Alexander, E Marqusee, J Lawrence, et al. (2004) Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 351 241-249.
130. AP Weetman (2004) Autoimmune thyroid disease. Autoimmunity 37 337-340.
131. M Dentice, A Bandyopadhyay, B Gereben, et al. (2005) The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol 7 698-705.
132. DA Fisher, EJ Schoen, S La Franchi, et al. (2000) The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism. J Clin Endocrinol Metab 85 2722-2727.
133. B Contempre, E Jauniaux, R Calvo, et al. (1993) Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 77 1719-1722.
134. A Stagnaro-Green (2009) Maternal thyroid disease and preterm delivery. J Clin Endocrinol Metab 94 21-25.
135. DA Fisher, JC Nelson, EI Carlton, et al. (2000) Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid 10 229-234.
136. J Abuid, DA Stinson and PR Larsen (1973) Serum triiodothyronine and thyroxine in the neonate and the acute increases in these hormones following delivery. J Clin Invest 52 1195-1199.
137. LA de Jesus, SD Carvalho, MO Ribeiro, et al. (2001) The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 108 1379-1385.
138. DA Fisher (2008) Thyroid system immaturities in very low birth weight premature infants. Semin Perinatol 32 387-397.
139. DA Fisher (2007) Thyroid function and dysfunction in premature infants. Pediatr Endocrinol Rev 4 317-328.
140. JL Shih and MS Agus (2009) Thyroid function in the critically ill newborn and child. Curr Opin Pediatr 21 536-540.
141. S Mariotti, C Franceschi, A Cossarizza, et al. (1995) The aging thyroid. Endocr Rev 16 686-715.
142. JM Hershman, AE Pekary, L Berg, et al. (1993) Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc 41 823-828.
143. EH Hoogendoorn, AR Hermus, F de Vegt, et al. (2006) Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 52 104-111.
144. GF Lewis, CA Alessi, JG Imperial, et al. (1991) Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab 73 843-849.
145. JL Chan, J Bullen, V Stoyneva, AM Depaoli, et al. (2005) Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess. J Clin Endocrinol Metab 90 1618-1624.
146. LO Byerley and D Heber (1996) Metabolic effects of triiodothyronine replacement during fasting in obese subjects. J Clin Endocrinol Metab 81 968-976.
147. S Onur, V Haas, A Bosy-Westphal, et al. (2005) L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol 152 179-184.
148. JE Danforth, ES Horton, M O’Connell, et al. (1979) Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest 64 1336-1347.
149. G Van den Berghe (2000) Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 143 1-13.
150. A Alkemade, EC Friesema, UA Unmehopa, et al. (2005) Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J Clin Endocrinol Metab 90 4322-4334.
151. C Fekete, S Sarkar, MA Christoffolete, et al. (2005) Bacterial lipopolysaccharide (LPS)-induced type 2 iodothyronine deiodinase (D2) activation in the mediobasal hypothalamus (MBH) is independent of the LPS-induced fall in serum thyroid hormone levels. Brain Res 1056 97-99.
152. A Boelen, MC Platvoet-Ter Schiphorst and WM Wiersinga (1993) Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 77 1695-1699.
153. RJ Koenig (2008) Modeling the nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes 15 466-469.
154. RP Peeters, PJ Wouters, E Kaptein, et al. (2003) Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88 3202-3211.
155. D Wadwekar and UM Kabadi (2004) Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy. Exp Clin Endocrinol Diabetes 112 373-377.
156. G Van den Berghe, P Wouters, F Weekers, et al. (1999) Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 84 1311-1323.
157. GA Brent and JM Hershman (1986) Thyroxine therapy in patients with severe nonthyroidal illness and low serum thyroxine concentrations. J Clin Endocrinol Metab 63 1-8.
158. PS Hamblin, SA Dyer, VS Mohr, et al. (1986) Relationship between thyrotropin and thyroxine changes during the recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 62 717-722.
159. E Bennett-Guerrero, JL Jimenez, WD White, et al. (1996) Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: a randomized, double-blind, placebo-controlled trial. Duke T3 study group. JAMA 275 687-692.
160. I Klein and S Danzi (2007) Thyroid disease and the heart. Circulation 116 1725-1735.
161. IM Jackson (1998) The thyroid axis and depression. Thyroid 8 951-956.
162. DJ Topliss, EL White and JR Stockigt (1980) Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab 50 52-56.
163. KB Ain, Y Mori and S Refetoff (1987) Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration. J Clin Endocrinol Metab 65 689-696.
164. E Marqusee, LE Braverman, JE Lawrence, et al. (2000) The effect of droloxifene and estrogen on thyroid function in postmenopausal women. J Clin Endocrinol Metab 85 4407-4410.
165. BM Arafah (1994) Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer. Ann Intern Med 121 247-251.
166. MI Surks, G Goswami and GH Daniels (2005) The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 90 5489-5496.
167. L Wartofsky and RA Dickey (2005) The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 90 5483-5488.
168. F Brucker-Davis, EH Oldfield, MC Skarulis, et al. (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84 476-486.
169. N Kuzuya, I Kinji and M Ishibashi (1990) Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, α-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. J Clin Endocrinol Metab 71 1103-1111.
170. R Wang, JC Nelson, RM Weiss, et al. (2000) Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid 10 31-39.
171. JC Nelson, RM Weiss and RB Wilcox (1994) Underestimates of serum free thyroxine (T 4) concentrations by free T 4 immunoassays. J Clin Endocrinol Metab 79 76-79.
172. JD Faix, HN Rosen and FR Velazquez (1995) Indirect estimation of thyroid hormone-binding proteins to calculate free thyroxine index: comparison of nonisotopic methods that use labeled thyroxine (“T-uptake”). Clin Chem 41 41-47.
173. JC Nelson and RM Weiss (1985) The effect of serum dilution on free thyroxine (T 4) concentrations in the low T 4 syndrome of nonthyroidal illness. J Clin Endocrinol Metab 61 239-246.
174. LM Demers and CA Spencer (2003) Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol (Oxf) 58 138-140.
175. B Afandi, R Vera, GC Schussler, et al. (2000) Concordant decreases of thyroxine and thyroxine binding protein concentrations during sepsis. Metabolism 49 753-754.
176. AD Toft, WJ Irvine, WM Hunter, et al. (1974) Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis. J Clin Endocrinol Metab 39 607-609.
177. RW Rees-Jones and PR Larsen (1977) Triiodothyronine and thyroxine content of desiccated thyroid tablets. Metabolism 26 1213-1218.
178. EM Kaptein (1996) Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 17 45-63.
179. V Bacci, GC Schussler and TB Kaplan (1982) The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab 54 1229-1235.
180. RE Weiss and S Refetoff (1999) Treatment of resistance to thyroid hormone—primum non nocere. J Clin Endocrinol Metab 84 401-404.
181. S Refetoff, RE Weiss and SJ Usala (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14 348-399.
182. H al-Adsani, LJ Hoffer and JE Silva (1997) Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab 82 1118-1125.
183. C Becker (1985) Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 6 432-440.
184. EL Mazzaferri, RJ Robbins, CA Spencer, et al. (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88 1433-1441.
185. Z Francis and M Schlumberger (2008) Serum thyroglobulin determination in thyroid cancer patients. Best Pract Res Clin Endocrinol Metab 22 1039-1046.
186. CA Spencer and JS Lopresti (2008) Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nat Clin Pract Endocrinol Metab 4 223-233.
187. M Schlumberger, A Hitzel, ME Toubert, et al. (2007) Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab 92 2487-2495.
188. CL Snozek, EP Chambers, CC Reading, et al. (2007) Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases. J Clin Endocrinol Metab 92 4278-4281.
189. B Rapoport and SM McLachlan (2001) Thyroid autoimmunity. J Clin Invest 108 1253-1259.
190. JG Hollowell, NW Staehling, WD Flanders, et al. (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87 489-499.
191. A Martin, G Barbesino and TF Davies (1999) T-cell receptors and autoimmune thyroid disease—signposts for T-cell-antigen driven diseases. Int Rev Immunol 18 111-140.
192. F Latrofa, P Pichurin, J Guo, et al. (2003) Thyroglobulin-thyroperoxidase autoantibodies are polyreactive, not bispecific: analysis using human monoclonal autoantibodies. J Clin Endocrinol Metab 88 371-378.
193. J Guo, Y Wang, B Rapoport, et al. (2000) Evidence for antigen presentation to sensitized T cells by thyroid peroxidase (TPO)-specific B cells in mice injected with fibroblasts co-expressing TPO and MHC class II. Clin Exp Immunol 119 38-46.
194. MPJ Vanderpump, WMG Tunbridge, JM French, et al. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 43 55-68.
195. AA Hayes, CM Akre and CA Gorman (1990) Iodine-131 treatment of Graves’ disease using modified early iodine-131 uptake measurements in therapy dose calculations. J Nucl Med 31 519-522.
196. G Medeiros-Neto, PS Kim, J Vono, et al. (1996) Congenital hypothyroid goiter with deficient thyroglobulin. J Clin Invest 98 2838-2844.
197. S Mariotti, E Martino, C Cupini, et al. (1982) Low serum thyroblobulin as a clue to the diagnosis of thyrotoxicosis factitia. N Engl J Med 307 410-412.